Neurogenic bladder (NB) is a common pediatric urological disease caused by a variety of neurological pathologies. Clean intermittent catheterization (CIC) has been the preferred method to empty bladder.
OBJECTIVE:
To investigate the effect of CIC on preserving bladder and upper urinary tract function in infants less than 1 year old with NB.
METHODS:
A retrospective analysis was conducted on 76 infants with NB. Patients were divided into two groups according to treatment initiation: the early CIC group (ECG) (<1 year old) and the late CIC group (LCG) (>3 years old).
RESULTS:
Bladder compliance (BC), safe bladder capacity (SBC) and maximum cystometric capacity (MCC) were significantly higher in the ECG than those in the LCG at 6 years of follow-up respectively (P < 0.05). The frequencies of vesicoureteral reflux (VUR) and urinary tract infection (UTI) in the ECG were significantly lower than those in the LCG (P < 0.05) at 6 years of follow-up. Two and nine patients exhibited mild renal damage in the ECG and LCG, respectively, resulting in a significant difference (P < 0.05) at 6 years of follow-up.
CONCLUSION:
Early CIC plays an important role in preserving bladder function and preventing UTI and renal deterioration in infants with NB, especially in the first year of life.
AbramsP, CardozoL, FallM., GriffithsD., RosierP., & UlmstenU. (2003). Standardisation Sub-Committee of the International Continence, S. The standardisation of terminology in lower urinary tract function: Report from the standardisation sub-committee of the International Continence Society. Urology, 61 (1), 37–49.
2.
ChaudhryR, BalsaraZ. R., Madden-FuentesR. J., WienerJ. S., RouthJ. C., SeedP., & RossS. S. (2017). Risk Factors Associated With Recurrent Urinary Tract Infection in Neurogenic Bladders Managed by Clean Intermittent Catheterization. Urology, 102, 213–218. doi:10.1016/j.urology.2016.12.049
3.
Di BenedettoP (2011). Clean intermittent self-catheterization in neuro-urology. Eur J Phys Rehabil Med, 47 (4), 651–659.
4.
EdelsteinR.A., BauerS. B., KellyM. D., DarbeyM. M., PetersC. A., AtalaA., & RetikA. B. (1995). The long-term urological response of neonates with myelodysplasia treated proactively with intermittent catheterization and anticholinergic therapy. J Urol, 154 (4), 1500–1504.
5.
ForsterC.S., HaslamD. B., JacksonE., & GoldsteinS. L. (2017). Utility of a routine urinalysis in children who require clean intermittent catheterization. J Pediatr Urol. doi:10.1016/j.jpurol.2017.01.016
6.
FrimbergerD, ChengE, & KroppB. P. (2012). The current management of the neurogenic bladder in children with spina bifida. Pediatr Clin North Am, 59 (4), 757–767. doi:s10.1016/j.pcl.2012.05.006
7.
GuerraL, LeonardM, & CastagnettiM. (2014). Best practice in the assessment of bladder function in infants. Ther Adv Urol, 6 (4), 148–164. doi:10.1177/1756287214528745
8.
GuttmannL, RichesE.W., WhitteridgeD., & JonasonP. H. A. (1947). Discussion on the Treatment and Prognosis of Traumatic Paraplegia. Proc R Soc Med, 40 (5), 219–232.
JosephD.B., BauerS. B., ColodnyA. H., MandellJ., & RetikA. B. (1989). Clean, intermittent catheterization of infants with neurogenic bladder. Pediatrics, 84 (1), 78–82.
11.
KochakarnW, Ratana-OlarnK, LertsithichaiP., & RoongreungsilpU. (2004). Follow-up of long-term treatment with clean intermittent catheterization for neurogenic bladder in children. Asian J Surg, 27 (2), 134–136. doi:10.1016/S1015-9584(09)60327-4
12.
KrygerJ (2008). Nonsurgical management of the neurogenic bladder in children. ScientificWorldJournal, 8, 1177–1186. doi:10.1100/tsw.2008.146
13.
LapidesJ, DioknoA.C., LoweB. S., & KalishM. D. (1974). Followup on unsterile intermittent self-catheterization. J Urol, 111 (2), 184–187.
14.
LarijaniF.J., MoghtaderiM., HajizadehN., & AssadiF. (2013). Preventing kidney injury in children with neurogenic bladder dysfunction. Int J Prev Med, 4 (12), 1359–1364.
15.
LiaoL (2015). Evaluation and Management of Neurogenic Bladder: What Is New in China?Int J Mol Sci, 16 (8), 18580–18600.
16.
Martinez-GarciaR, Ubeda-SansanoM.I., Diez-DomingoJ., Perez-HoyosS., & Gil-SalomM. (2014). It is time to abandon “expected bladder capacity.” Systematic review and new models for children’s normal maximum voided volumes. Neurourol Urodyn, 33 (7), 1092–1098. doi:10.1002/nau.22452
17.
McGuireE.J,, WoodsideJ. R., & BordenT. A. (1983). Upper urinary tract deterioration in patients with myelodysplasia and detrusor hypertonia: A followup study. J Urol, 129 (4), 823–826.
18.
McGuireE.J., WoodsideJ. R., BordenT. A., & WeissR. M. (1981). Prognostic value of urodynamic testing in myelodysplastic patients. J Urol, 126 (2), 205–209.
19.
NazarkoL (2012). Intermittent self-catheterisation: Past, present and future. Br J Community Nurs, 17 (9), 408, 410–412. doi:10.12968/bjcn.2012.17.9.408
20.
NewmanD.K., & WillsonM. M. (2011). Review of intermittent catheterization and current best practices. Urol Nurs, 31 (1), 12–28, 48; quiz 29.
21.
SchaferW, AbramsP. LiaoL., MattiassonA., PesceF., SpangbergA., International Continence, S. (2002). Good urodynamic practices: Uroflowmetry, filling cystometry, and pressure-flow studies. Neurourol Urodyn, 21 (3), 261–274.
22.
SethJ.H., HaslamC., & PanickerJ. N. (2014). Ensuring patient adherence to clean intermittent self-catheterization. Patient Prefer Adherence, 8, 191–198. doi:10.2147/PPA.S49060
23.
SidiA.A., PengW., & GonzalezR. (1986). Vesicoureteral reflux in children with myelodysplasia: Natural history and results of treatment. J Urol, 136 (1 Pt 2), 329–331.
24.
SturmR.M., & ChengE. Y. (2016). The Management of the Pediatric Neurogenic Bladder. Curr Bladder Dysfunct Rep, 11, 225–233. doi:10.1007/s11884-016-0371-6
25.
WuH, BaskinL, KoganB. (1997). Neurogenic bladder dysfunction due to myelomeningocele: Neonatal versus childhood treatment. J Urol, 157 (6), 2295–2297.
26.
WyndaeleJ.J., BraunerA., GeerlingsS. E., BelaK., PeterT., & Bjerklund-JohansonT. E. (2012). Clean intermittent catheterization and urinary tract infection: Review and guide for future research. BJU Int, 110 (11 Pt C), E910–917, doi:10.1111/j.1464-410X.2012.11549.x
